Clincosm LogoSign in Get a demo

Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device

Sponsor
Hospital for Special Surgery, New York (Other)
Overall Status
Approved for marketing
CT.gov ID
NCT02244775
Collaborator
(none)
1
Location

Study Details

Study Description

Brief Summary

The purpose of this study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device.

Condition or Disease Intervention/Treatment Phase
  • Device: SR™MCP

Detailed Description

The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device. Use of the SR™ MCP is approved for humanitarian use by the FDA when either the patient is in need of a revision of failed MCP prothesis(es) or the patient expects to place his/her hand under loading situation which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint.

Study Design

Study Type:
Expanded Access
Official Title:
Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • patient is in need of a revision of failed MCP prosthesis(es)

    • patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint

    Exclusion Criteria:

    • patient is not in need of a revision of a failed MCP prothesis(es)

    • patient is eligible to use an alternative implant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital for Special Surgery New York New York United States 10021

    Sponsors and Collaborators

    • Hospital for Special Surgery, New York

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hospital for Special Surgery, New York
    ClinicalTrials.gov Identifier:
    NCT02244775
    Other Study ID Numbers:
    • 2013-090
    First Posted:
    Sep 19, 2014
    Last Update Posted:
    Sep 19, 2014
    Last Verified:
    Sep 1, 2014
    Keywords provided by Hospital for Special Surgery, New York
    osteo-arthritis
    post traumatic arthritis

    Study Results

    No Results Posted as of Sep 19, 2014